Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Radiosurgery alone for 5 or more brain metastases: expert opinion survey.

Knisely JP, Yamamoto M, Gross CP, Castrucci WA, Jokura H, Chiang VL.

J Neurosurg. 2010 Dec;113 Suppl:84-9.

PMID:
21121790
2.

Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.

Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB.

J Neurosurg. 2016 Apr;124(4):1018-24. doi: 10.3171/2015.4.JNS1573. Epub 2015 Oct 16.

PMID:
26473783
3.

Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.

Grandhi R, Kondziolka D, Panczykowski D, Monaco EA 3rd, Kano H, Niranjan A, Flickinger JC, Lunsford LD.

J Neurosurg. 2012 Aug;117(2):237-45. doi: 10.3171/2012.4.JNS11870. Epub 2012 May 25.

PMID:
22631694
4.
5.

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1097-106.

PMID:
15234044
6.

Gamma Knife radiosurgery for brain metastases from primary breast cancer.

Kased N, Binder DK, McDermott MW, Nakamura JL, Huang K, Berger MS, Wara WM, Sneed PK.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1132-40. doi: 10.1016/j.ijrobp.2008.12.031. Epub 2009 Apr 3.

PMID:
19345514
8.

Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.

Frakes JM, Figura NB, Ahmed KA, Juan TH, Patel N, Latifi K, Sarangkasiri S, Strom TJ, Chinnaiyan P, Rao NG, Etame AB.

J Neurosurg. 2015 Nov;123(5):1261-7. doi: 10.3171/2014.12.JNS141919. Epub 2015 Jul 3.

PMID:
26140482
9.

Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration.

Gonda DD, Kim TE, Goetsch SJ, Kawabe T, Watanabe S, Alksne JF, Hattangadi JA, Nitta M, Ott K, Hodgens DW, Carter BS, Yamamoto M, Chen CC.

Eur J Cancer. 2014 Apr;50(6):1148-58. doi: 10.1016/j.ejca.2014.01.001. Epub 2014 Feb 12.

PMID:
24529832
10.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
11.

Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. Clinical article.

Sheehan JP, Yen CP, Nguyen J, Rainey JA, Dassoulas K, Schlesinger DJ.

J Neurosurg. 2011 Mar;114(3):763-8. doi: 10.3171/2010.2.JNS091539. Epub 2010 Mar 12.

PMID:
20225924
12.

Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer.

Wegner RE, Olson AC, Kondziolka D, Niranjan A, Lundsford LD, Flickinger JC.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e21-7. doi: 10.1016/j.ijrobp.2011.01.001. Epub 2011 Feb 23.

PMID:
21345622
13.

Treatment of five or more brain metastases with stereotactic radiosurgery.

Hunter GK, Suh JH, Reuther AM, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Chao ST.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1394-8. doi: 10.1016/j.ijrobp.2011.10.026. Epub 2011 Dec 29.

PMID:
22209150
14.

Radiographic response of brain metastasis after linear accelerator radiosurgery.

Rahman M, Cox JB, Chi YY, Carter JH, Friedman WA.

Stereotact Funct Neurosurg. 2012;90(2):69-78. doi: 10.1159/000334669. Epub 2012 Jan 27.

PMID:
22286386
15.

The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.

Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1125-32.

PMID:
15990018
16.

Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival.

Banfill KE, Bownes PJ, St Clair SE, Loughrey C, Hatfield P.

Br J Neurosurg. 2012 Oct;26(5):674-8. doi: 10.3109/02688697.2012.690913. Epub 2012 Jul 1.

PMID:
22747250
17.

Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.

Rava P, Leonard K, Sioshansi S, Curran B, Wazer DE, Cosgrove GR, Norén G, Hepel JT.

J Neurosurg. 2013 Aug;119(2):457-62. doi: 10.3171/2013.4.JNS121751. Epub 2013 May 10.

PMID:
23662828
18.

Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.

Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD.

J Neurosurg. 2011 Mar;114(3):769-79. doi: 10.3171/2010.5.JNS1014. Epub 2010 Jun 4.

PMID:
20524829
19.

Treatment trends for patients with brain metastases: Does practice reflect the data?

Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, Steinberg ML, Lee P.

Cancer. 2017 Jun 15;123(12):2274-2282. doi: 10.1002/cncr.30607. Epub 2017 Feb 8.

PMID:
28178376
20.

Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) scores.

Chernov MF, Nakaya K, Izawa M, Hayashi M, Usuba Y, Kato K, Muragaki Y, Iseki H, Hori T, Takakura K.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1492-8. Epub 2007 Feb 2.

PMID:
17276617

Supplemental Content

Support Center